Background There is evidence that the adaptive or acquired immune system is one of the
crucial variables in differentiating the course of coronavirus disease 2019 (COVID-19) …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the 29
causative pathogen of Coronavirus disease 2019 (COVID-19), has resulted in over 650 30 …

We developed a novel intranasal SARS-CoV-2 subunit vaccine called NARUVAX-C19/Nano
based on the spike protein receptor-binding domain (RBD) entrapped in mannose …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) damages multiple
organs, including the thyroid, by direct invasion and cell entry via angiotensin‐converting …

This study is a successor of our previous work concerning changes in the chemokine profile
in infection that are associated with different SARS-CoV-2 genetic variants. The goal of our …

Clinical outcomes from infection with SARS-CoV-2, the cause of the COVID-19 pandemic,
are remarkably variable ranging from asymptomatic infection to severe pneumonia and …

Various immunopathological events characterize the systemic acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. Moreover, it has been reported that coronavirus …

The COVID-19 pandemic has highlighted the profound impact of the SARS-CoV-2 virus as a
significant threat to human health. There is an urgent need to develop a comprehensive …

Long Covid, now also reported in children, has become increasingly alarming. Perhaps a
third of those who develop MIS-C go on to experience Long Covid. Etiology is elusive. The …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is persistently
threatening the lives of thousands of individuals globally. It triggers pulmonary oedema …